Formulation White Papers & Case Studies
-
Supporting Complex Manufacturing For Liquid And Lyophilized Drug Products
10/24/2025
Aseptic fill and finish operations gain efficiency and precision with modular isolator technology, inline weight checks, and lyophilization, which are ideal for mRNA-LNPs and other sensitive modalities.
-
How Lipid Nanoparticles Enable Next-Gen Delivery
10/20/2025
Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.
-
Virus Reduction And Impurity Removal
10/16/2025
Examine a DOE-based study that reveals how buffer conditions impact virus and impurity clearance using a mixed-mode resin, as well as gain practical guidance for optimizing downstream purification.
-
High Purity And Recovery With Adjustable Selectivity In Downstream Purification Processes
10/16/2025
Discover a resin that enables high-yield purification of complex biomolecules, as well as supports fast flow rates, consistent recovery, and scalable performance for downstream processing.
-
Overcoming Excipient Risks And Challenges For Parenteral Formulations
8/27/2025
Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.
-
Stabilization Of RNA-Loaded Lipid Nanoparticles By Lyophilization
8/15/2025
Discover how lyophilization enhances RNA-based therapeutics by enabling storage at higher temperatures, which simplifies cold-chain logistics while preserving nanoparticle integrity and biological activity.
-
Tangential Flow Filtration Of LNPs Results In 10X Concentration Within 20 Minutes
8/5/2025
Dive into a study that details how a single-pass tangential flow filtration system can achieve a tenfold concentration of liposomal nanoparticles in under 20 minutes.
-
Enhanced Structural Characterization Of Thermal Unfolding With MMS
7/21/2025
Explore the power of Microfluidic Modulation Spectroscopy (MMS) in resolving distinct melting behaviors and domain-specific unfolding events for biologics, providing crucial structural insights for development and formulation.
-
Non Animal Origin Squalene For High-Risk Applications
7/21/2025
Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.
-
Structural Characterization Of GLP-1 Analogues And Formulations Using MMS
7/9/2025
Discover how MMS quantifies peptide concentrations and identifies structural differences in GLP-1 and its commercial analogues across various buffer systems.